Skip to content

Comparison of the effectiveness of Hypnotherapy, Cognitive-Behavioral therapy (CBT) and Cognitive-Behavioral Hypnotherapy (CBH) treatment on Resilience, Sleep quality, Sexual satisfaction and Physical symptoms in women with Fibromyalgia syndrome

Comparison of the effectiveness of Hypnotherapy, Cognitive-Behavioral therapy (CBT) and Cognitive-Behavioral Hypnotherapy (CBH) treatment on Resilience, Sleep quality, Sexual satisfaction and Physical symptoms in women with Fibromyalgia syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191130045558N1
Enrollment
12
Registered
2020-08-02
Start date
2020-07-26
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypnotherapy, Cognitive Behavioral Therapy ,Cognitive Behavioral Hypnotherapy, Resiliency, Sleep Quality, Sexual ?Satisfaction,Physical Symptoms, Fibromyalgial syndrome. Fibromyalgia

Interventions

Intervention 1: First Intervention group: Hypnotherapy is performed in 8 sessions per week, one session of 60 minutes which will be hold individually. Intervention 2: Second Intervention group: Cognit

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Not receiving coherent psychological therapies. Married women Age 20 to 60 Having a minimum level of diploma education Patient consent to participate in the study and sign a written consent No Psychotic disorder No substance abuse No serious medical illnesses; Includes severe liver and kidney failure Not having serious thoughts of self harm and debtors Not having Antisocial personality disorder

Exclusion criteria

Exclusion criteria: Serious thoughts of harming yourself and others Having severe liver and kidney failure Having Antisocial Personality disorder Substanse abuse Having Psychotic Disorders Single women Less than 20 and above 60 years old Under diploma degree

Design outcomes

Primary

MeasureTime frame
Physical Symptoms. Timepoint: 20 days before therapy, after 2nd, 4th, 6th, 7th and 8th therapy sessions, follow up 1 and 3 months after the end of therapy. Method of measurement: Paul and Enrit Physical Symptoms Questionnaire.;Resiliency. Timepoint: 20 days before therapy, after 2nd, 4th, 6th, 7th and 8th therapy sessions, follow up 1 and 3 months after the end of therapy. Method of measurement: Conner and Davidson Resiliency Questionnaire.;Sleep Quality. Timepoint: 20 days before therapy, after 2nd, 4th, 6th, 7th and 8th therapy sessions, follow up 1 and 3 months after the end of therapy. Method of measurement: Peterzburg Sleep Quality Questionnaire.;Sexual Satisfaction. Timepoint: 20 days before therapy, after 2nd, 4th, 6th, 7th and 8th therapy sessions, follow up 1 and 3 months after the end of therapy. Method of measurement: Roshan Sexual Satisfaction Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Kolbadinejad

Islamic Azad University

Mkolbadi483@gmail.com+98 17 3252 3853

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026